These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36945029)

  • 1. The long-term effects of Kerala Diabetes Prevention Program on diabetes incidence and cardiometabolic risk: a study protocol.
    Haregu T; Lekha TR; Jasper S; Kapoor N; Sathish T; Panniyammakal J; Tapp R; Thankappan KR; Mahal A; Absetz P; Fisher EB; Oldenburg B
    BMC Public Health; 2023 Mar; 23(1):539. PubMed ID: 36945029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster randomised controlled trial of a peer-led lifestyle intervention program: study protocol for the Kerala diabetes prevention program.
    Sathish T; Williams ED; Pasricha N; Absetz P; Lorgelly P; Wolfe R; Mathews E; Aziz Z; Thankappan KR; Zimmet P; Fisher E; Tapp R; Hollingsworth B; Mahal A; Shaw J; Jolley D; Daivadanam M; Oldenburg B
    BMC Public Health; 2013 Nov; 13():1035. PubMed ID: 24180316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program.
    Thankappan KR; Sathish T; Tapp RJ; Shaw JE; Lotfaliany M; Wolfe R; Absetz P; Mathews E; Aziz Z; Williams ED; Fisher EB; Zimmet PZ; Mahal A; Balachandran S; D'Esposito F; Sajeev P; Thomas E; Oldenburg B
    PLoS Med; 2018 Jun; 15(6):e1002575. PubMed ID: 29874236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala diabetes prevention program (K-DPP).
    Mathews E; Thomas E; Absetz P; D'Esposito F; Aziz Z; Balachandran S; Daivadanam M; Thankappan KR; Oldenburg B
    BMC Public Health; 2018 Jan; 17(1):974. PubMed ID: 29298703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.
    Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A
    BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A group-based lifestyle intervention for diabetes prevention in low- and middle-income country: implementation evaluation of the Kerala Diabetes Prevention Program.
    Aziz Z; Mathews E; Absetz P; Sathish T; Oldroyd J; Balachandran S; Shetty SS; Thankappan KR; Oldenburg B
    Implement Sci; 2018 Jul; 13(1):97. PubMed ID: 30021592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a lifestyle intervention on cardiovascular risk among high-risk individuals for diabetes in a low- and middle-income setting: Secondary analysis of the Kerala Diabetes Prevention Program.
    Lotfaliany M; Sathish T; Shaw J; Thomas E; Tapp RJ; Kapoor N; Thankappan KR; Oldenburg B
    Prev Med; 2020 Oct; 139():106068. PubMed ID: 32194098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a diabetes prevention program for rural women with prior gestational diabetes mellitus: study protocol of a multi-site randomized clinical trial.
    Guo J; Tang Y; Wiley J; Whittemore R; Chen JL
    BMC Public Health; 2018 Jun; 18(1):809. PubMed ID: 29954367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: study protocol for a randomized controlled trial.
    Shih ST; Davis-Lameloise N; Janus ED; Wildey C; Versace VL; Hagger V; Asproloupos D; O'Reilly S; Phillips PA; Ackland M; Skinner T; Oats J; Carter R; Best JD; Dunbar JA;
    Trials; 2013 Oct; 14():339. PubMed ID: 24135085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
    ; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
    Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle change in Kerala, India: needs assessment and planning for a community-based diabetes prevention trial.
    Daivadanam M; Absetz P; Sathish T; Thankappan KR; Fisher EB; Philip NE; Mathews E; Oldenburg B
    BMC Public Health; 2013 Feb; 13():95. PubMed ID: 23375152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline characteristics of participants in the Kerala Diabetes Prevention Program: a cluster randomized controlled trial of lifestyle intervention in Asian Indians.
    Sathish T; Oldenburg B; Tapp RJ; Shaw JE; Wolfe R; Sajitha B; D'Esposito F; Absetz P; Mathews E; Zimmet PZ; Thankappan KR
    Diabet Med; 2017 May; 34(5):647-653. PubMed ID: 27279083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scale-up of the Kerala Diabetes Prevention Program (K-DPP) in Kerala, India: implementation evaluation findings.
    Ravindranath R; Oldenburg B; Balachandran S; Mini GK; Mahat K; Sathish T; Thankappan KR
    Transl Behav Med; 2020 Feb; 10(1):5-12. PubMed ID: 32011723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
    Lim LL; Lau ESH; Fu AWC; Ray S; Hung YJ; Tan ATB; Chamnan P; Sheu WHH; Chawla MS; Chia YC; Chuang LM; Nguyen DC; Sosale A; Saboo BD; Phadke U; Kesavadev J; Goh SY; Gera N; Huyen Vu TT; Ma RCW; Lau V; Luk AOY; Kong APS; Chan JCN;
    JAMA Netw Open; 2021 Apr; 4(4):e217557. PubMed ID: 33929522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South Asian Women With Recent Gestational Diabetes: A Randomized Clinical Trial.
    Tandon N; Gupta Y; Kapoor D; Lakshmi JK; Praveen D; Bhattacharya A; Billot L; Naheed A; de Silva A; Gupta I; Farzana N; John R; Ajanthan S; Divakar H; Bhatla N; Desai A; Pathmeswaran A; Prabhakaran D; Joshi R; Jan S; Teede H; Zoungas S; Patel A;
    JAMA Netw Open; 2022 Mar; 5(3):e220773. PubMed ID: 35234881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivation and Problem Solving Versus Mobile 360° Videos to Promote Enrollment in the National Diabetes Prevention Program's Lifestyle Change Program Among People With Prediabetes: Protocol for a Randomized Trial.
    Gibson B; Simonsen S; Barton J; Zhang Y; Altizer R; Lundberg K; Wetter DW
    JMIR Res Protoc; 2021 Jun; 10(6):e28884. PubMed ID: 34125075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial.
    Damschroder LJ; Moin T; Datta SK; Reardon CM; Steinle N; Weinreb J; Billington CJ; Maciejewski ML; Yancy WS; Hughes M; Makki F; Richardson CR
    Implement Sci; 2015 May; 10():68. PubMed ID: 25962598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk outcome and program evaluation of a cluster randomised controlled trial of a community-based, lay peer led program for people with diabetes.
    Riddell MA; Dunbar JA; Absetz P; Wolfe R; Li H; Brand M; Aziz Z; Oldenburg B;
    BMC Public Health; 2016 Aug; 16(1):864. PubMed ID: 27558630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.
    Korczak D; Dietl M; Steinhauser G
    GMS Health Technol Assess; 2011 Apr; 7():Doc02. PubMed ID: 21468290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.